Applied Molecular TransportÂ Inc (AMTI)

Name: Applied Molecular TransportÂ Inc (AMTI) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Applied Molecular TransportÂ Inc (AMTI)

Stock Card

$0.26

$0.00 (0.00%)

As on 29-Dec-2023 09:30EDT

Market cap

$11 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

0.7

Div. Yield

0 %

Applied Molecular TransportÂ Inc (AMTI) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 0.26 High: 0.26

52 Week Range

Low: -- High: --

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$-23 Mln
ROE

-1.6 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

0.1
Debt to Equity

0
Book Value

$--
EPS

$-1.9
Face value

--
Shares outstanding

41,849,000

5 Years Aggregate

CFO

$-289.82 Mln

EBITDA

$-343.29 Mln

Net Profit

$-344.25 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Applied Molecular TransportÂ Inc (AMTI)	-37.4	46.9	59.4	-23.8	-80.2	--	--
BSE Sensex^*	-9.6	-2.0	3.1	-4.7	5.4	6.0	10.4
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 29-Dec-2023 | *As on 02-Sep-2026 | #As on 26-Oct-2023

Company	2023	2022	2021
Applied Molecular TransportÂ Inc (AMTI)	-37.4	-97.0	-54.6
S&P Small-Cap 600	13.9	-17.4	25.3
BSE Sensex	18.7	4.4	22.0

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About Applied Molecular TransportÂ Inc (AMTI)

Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead... product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trials to treat patients with chronic pouchitis, as well as is in Phase II development to treat patients with rheumatoid arthritis. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral and respiratory biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California. As of December 27, 2023, Applied Molecular Transport Inc. operates as a subsidiary of Cyclo Therapeutics, Inc. Read more

Exec. Chairman

Mr. Graham K. Cooper
Exec. Chairman

Mr. Graham K. Cooper
Headquarters

South San Francisco, CA
Website

https://www.appliedmt.com

FAQs for Applied Molecular TransportÂ Inc (AMTI)

What is the current share price of Applied Molecular TransportÂ Inc (AMTI) Today?

The share price of Applied Molecular TransportÂ Inc (AMTI) is $0.26 (NASDAQ) as of 29-Dec-2023 09:30 EDT. Applied Molecular TransportÂ Inc (AMTI) has given a return of -80.18% in the last 3 years.

What is the current PB & PE ratio of Applied Molecular TransportÂ Inc (AMTI)?

Since, TTM earnings of Applied Molecular TransportÂ Inc (AMTI) is negative, P/E ratio is not available.
The P/B ratio of Applied Molecular TransportÂ Inc (AMTI) is 0.68 times as on 08-Jan-2024, a 87 discount to its peers’ median range of 5.18 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2022	-0.13	0.27
2021	-5.59	3.29
2020	-16.80	8.23
2019	--	--
2018	--	--

What is the 52 Week High and Low of Applied Molecular TransportÂ Inc (AMTI)?

The 52-week high and low of Applied Molecular TransportÂ Inc (AMTI) are Rs -- and Rs -- as of 03-Sep-2026.

What is the market cap of Applied Molecular TransportÂ Inc (AMTI)?

Applied Molecular TransportÂ Inc (AMTI) has a market capitalisation of $ 11 Mln as on 08-Jan-2024. As per SEBI classification, it is a Small Cap company.

Should I invest in Applied Molecular TransportÂ Inc (AMTI)?

Before investing in Applied Molecular TransportÂ Inc (AMTI), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.